Stock Events

Stock Events

Fate Therapeutics (FATE) Q2 2026 Earnings

May 13Confirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-0.35

-0.32

-0.29

-0.26

Details

Expected EPS

-0.28

Actual EPS

-0.26

Surprise EPS

0.02

Surprise Percent

+7.14%

Description

⁨Fate Therapeutics⁩ (⁦FATE⁩) has reported earnings of ⁦-0.26⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.